Koss Olinger Consulting, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Koss Olinger Consulting, LLC

  • $1.14 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$7.06 - $15.52 $26,489 - $58,231
3,752 Added 19.84%
22,660 $291,000
Q2 2022

Jul 08, 2022
BUY
$6.23 - $8.57 $23,823 - $32,771
3,824 Added 25.35%
18,908 $133,000
Q1 2022

May 06, 2022
BUY
$5.31 - $8.31 $24,765 - $38,757
4,664 Added 44.76%
15,084 $125,000
Q4 2021

Feb 07, 2022
BUY
$5.21 - $7.45 $54,288 - $77,629
10,420 New
10,420 $71,000

Others Institutions Holding CPRX

# of Institutions
327
Shares Held
94.1M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.33B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Koss Olinger Consulting, LLC Portfolio

Follow Koss Olinger Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Koss Olinger Consulting, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email